Trial intelligence / Profile preview

Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail Approach

NCT03772262Phase 1Completed

Sponsor
Washington State University
Start
Apr 2018
Primary completion
Nov 2018
Countries
1
01

Overview

Phase 1, open-label trial (2 arms), sponsored by Washington State University. Primary endpoint: Area Under the Curve ratio. Started Apr 2018; status: completed.

Beyond the preview

Go deeper on NCT03772262.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03772262.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call